These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34896914)

  • 1. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
    Zhang W; Xin J; Lai J; Zhang W
    Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA
    Xu YJ; Zhao JM; Ni XF; Wang W; Hu WW; Wu CP
    Epigenomics; 2021 Aug; 13(16):1281-1297. PubMed ID: 34523356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.
    Wang W; Li L; Zhao L
    J Cell Mol Med; 2021 Nov; 25(21):9927-9938. PubMed ID: 34651416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].
    Yang C; Xue JG
    Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
    Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B
    Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
    Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
    J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
    Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
    Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis.
    Xing Z; Li S; Xing J; Yu G; Wang G; Liu Z
    Lab Invest; 2022 Jun; 102(6):602-612. PubMed ID: 35152275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
    Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
    Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA OGFRP1/miR-149-5p/IL-6 axis regulates prostate cancer chemoresistance.
    Wang C; Ding T; Yang D; Zhang P; Hu X; Qin W; Zheng J
    Pathol Res Pract; 2021 Aug; 224():153535. PubMed ID: 34293716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR-564/ZIC2 axis.
    Gu H; Duan Z
    J Gene Med; 2022 Mar; 24(3):e3403. PubMed ID: 34904327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.
    Wang Z; Zhang X; Li W; Su Q; Huang Z; Zhang X; Chen H; Mo C; Huang B; Ou W; Chen J; Zhao G; Chen L; Shao L
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer].
    Chen T; Dong Y; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
    Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
    J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis.
    Cao H; Wang D; Sun P; Chen L; Feng Y; Gao R
    Aging (Albany NY); 2021 Oct; 13(19):23096-23107. PubMed ID: 34613933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
    Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
    Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis.
    Zeng C; Ye S; Chen Y; Zhang Q; Luo Y; Gai L; Luo B
    J Immunol Res; 2021; 2021():9289719. PubMed ID: 34988230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.